Search results
Can Esketamine Prevent Postpartum Depression?
Medscape· 2 days agoData suggest that a low dose of esketamine immediately after childbirth reduces major depressive episodes in women with prenatal depression.
Biogen sees ‘encouraging’ trends for postpartum depression drug
BioPharma Dive via Yahoo Finance· 4 days agoDive Brief: Biogen has seen “encouraging early trends” in the launch of its postpartum depression...
Biogen Stock Surges After Two Notable Products Walloped Sales Expectations
Investor's Business Daily· 3 days agoThere are now more than 1,100 patients in the U.S. on the drug, RBC's Abrahams said. That's 24% of...
Is Natural Hormone Replacement Therapy Better?
Verywell Health via Yahoo News· 2 days agoHowever, your body cannot convert the diosgenin in wild yam into progesterone; this can only be done in a lab. All supplements carry a risk of side...
Biogen to invest more in launch of Alzheimer’s drug Leqembi
BioPharma Dive via Yahoo Finance· 4 days agoEven though Biogen and Wall Street had high hopes for Leqembi, getting the drug to patients has...
Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
Zacks via Yahoo Finance· 2 days agoSage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales...
Biogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings
Benzinga via Yahoo Finance· 3 days agoThe company reported sales of $2.29 billion, down 7% year over year and missing the consensus of...
Mental illness is the leading cause of pregnancy-related deaths. What's being done
Delaware Online | The News Journal via Yahoo News· 4 days agoMany of these women expressed experiencing postpartum depression — an issue that affects one in...
Severity of TRD Predicts Ketamine vs ECT Response
Medscape· 4 days agoThe severity of TRD appeared to predict response to IV ketamine vs ECT. However, experts said more research is needed before drawing any definitive conclusions.
Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
Zacks via Yahoo Finance· 4 days agoBiogen's (BIIB) first-quarter earnings beat estimates but sales miss the mark. While sales of key...